Elbit Imaging-M Ltd.

Foreign Filer Report • Nov 19, 2018

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934

For the month of November, 2018

Commission File Number 000-28996

ELBIT IMAGING LTD. (Translation of Registrant's Name into English)

5 SHIMSHON STREET, PETACH TIKVA, ISRAEL

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒ Form 40-F ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ____

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ____

EXHIBIT 99.1 OF THIS REPORT ON FORM 6-K IS HEREBY INCORPORATED BY REFERENCE INTO ELBIT IMAGING LTD.'S REGISTRATION STATEMENT ON FORM F-1 (REGISTRATION STATEMENTS NO. 333-194519), REGISTRATION STATEMENT ON FORM F-3 (REGISTRATION STATEMENT NO. 333-172122) AND REGISTRATION STATEMENTS ON FORM S-8 (REGISTRATION STATEMENTS NOS. 333-117509, 333-130852, 333-136684 AND 333-152820), AND TO BE A PART THEREOF FROM THE DATE ON WHICH THIS REPORT IS SUBMITTED, TO THE EXTENT NOT SUPERSEDED BY DOCUMENTS OR REPORTS SUBSEQUENTLY FILED OR FURNISHED.

CONTENTS

This Report on Form 6-K of Elbit consists of the following documents, which is attached hereto and incorporated by reference herein:

99.1. Summary of Gamida-cell Ltd. financial reports (not reviewed) for the nine-month period ended on September 30, 2018

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: November 18, 2018 By: /s/ Ron Hadassi

ELBIT IMAGING LTD. (Registrant)

Ron Hadassi CEO and Chairman of the Board of Directors It is hereby clarified that this summary is published solely for the sake of caution and in light of the Company's intention to execute a Buy-Back plan of its (series I) notes.

Gamida Cell LTD.

	September 30, 2018	December 31, 2017
	Thousands usd
Current assets	24,697	43,622
Non current assents	3,815	1,300
Total Assets	28,512	44,922
Current liabilities	7,299	4,576
Non current liabilities	26,068	17,390
Total Liabilities	33,367	21,966
Shareholders' equity (deficit)	(4,855)	22,956
Total liabilities and shareholders' equity	28,512	44,922

		Nine months ended September 30,		Three months ended September 30,
	2018	2017 Thousands usd	2018	2017
Research and development expenses	17,169	10,715	5,132	3,374
General and administrative expenses	7,008	2,753	2,438	980
Financing income, net	6,126	(207)	2,252	(417)
Other comprehensive (profit) loss:	13	-	(122)	-
Total comprehensive loss for the period	30,316	13,261	9,700	3,937